title: Treatment of chronic granulocytic leukemia with the active form of vitamin D3.
authors.forename: T
authors.initials: T
authors.lastname: Onishi
authors.forename: S
authors.initials: S
authors.lastname: Morimoto
authors.forename: S
authors.initials: S
authors.lastname: Takamoto
authors.forename: T
authors.initials: T
authors.lastname: Hironaka
authors.forename: K
authors.initials: K
authors.lastname: Fukuo
authors.forename: S
authors.initials: S
authors.lastname: Imanaka
authors.forename: E
authors.initials: E
authors.lastname: Koh
authors.forename: H
authors.initials: H
authors.lastname: Yamamoto
authors.forename: T
authors.initials: T
authors.lastname: Tsunetoshi
authors.forename: T
authors.initials: T
authors.lastname: Yonezawa
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002112:Calcifediol; D006801:Humans; D006887:Hydroxycholecalciferols / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000097:blood / Q000188:drug therapy*; D007958:Leukocyte Count / Q000187:drug effects; D008297:Male
chemical_list: D000970:Antineoplastic Agents; D006887:Hydroxycholecalciferols; D002112:Calcifediol; C008088:alfacalcidol